1. Home
  2. ARTL vs CETX Comparison

ARTL vs CETX Comparison

Compare ARTL & CETX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artelo Biosciences Inc.

ARTL

Artelo Biosciences Inc.

HOLD

Current Price

$1.84

Market Cap

3.4M

Sector

Health Care

ML Signal

HOLD

Logo Cemtrex Inc.

CETX

Cemtrex Inc.

HOLD

Current Price

$2.60

Market Cap

3.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARTL
CETX
Founded
2011
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.4M
3.5M
IPO Year
N/A
1998

Fundamental Metrics

Financial Performance
Metric
ARTL
CETX
Price
$1.84
$2.60
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$30.00
N/A
AVG Volume (30 Days)
1.3M
140.1K
Earning Date
11-12-2025
12-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$76,095,551.00
Revenue This Year
N/A
$19.77
Revenue Next Year
N/A
$15.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.50
52 Week Low
$1.52
$2.50
52 Week High
$28.60
$57.75

Technical Indicators

Market Signals
Indicator
ARTL
CETX
Relative Strength Index (RSI) 33.96 35.87
Support Level $1.62 $2.86
Resistance Level $1.98 $3.42
Average True Range (ATR) 0.19 0.42
MACD 0.11 -0.08
Stochastic Oscillator 69.53 4.41

Price Performance

Historical Comparison
ARTL
CETX

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About CETX Cemtrex Inc.

Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes, Security segment, Industrial Services segment and the corporate segment. The security segment provides end to end security to all industrial, corporate and governmental security via owned subsidiary Vicon. Whereas AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment. It geographically operates in USA, UK and India, with maximum of revenue from USA.

Share on Social Networks: